Skip to Main Content

Paper Details

Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60.
Cancers (Basel)
0
2022
ABC, ABC subtype DLBCL, COO, DLBCL, Diffuse Large B-Cell Lymphoma, Patients, activated B-cell, cancer, diffuse large B-cell lymphoma, gene, ibrutinib, patient, patients

Datasets

Release 1.2